Semaglutide and cardiovascular outcomes by baseline HbA1c in diabetes: the SUSTAIN 6 and PIONEER 6 trials

被引：1
|
作者：
Mellbin, Linda G. [1 ,2 ]
Bhatt, Deepak L. [3 ]
David, Jens-Peter [4 ]
Ekstrom, Kathrine [4 ]
Petrie, Mark C. [5 ]
Rasmussen, Soren [4 ]
Vilsboll, Tina [6 ]
机构：
[1] Karolinska Inst, Dept Med Solna, Eugeniavagen 27, S-17164 Solna, Stockholm, Sweden
[2] Karolinska Univ Hosp, Heart Vasc & Neuro Theme, K2 Med,K2 Kardio Pernow J, S-17177 Solna, Stockholm, Sweden
[3] Mt Sinai Fuster Heart Hosp, Icahn Sch Med Mt Sinai, New York, NY USA
[4] Novo Nord A S, Soborg, Denmark
[5] Univ Glasgow, Sch Cardiovasc & Metab Hlth, Glasgow City, Scotland
[6] Univ Copenhagen, Steno Diabet Ctr Copenhagen, Clin Res, Copenhagen, Denmark
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷 / 15期
关键词：
Cardiovascular outcomes trial; Glucagon-like peptide-1 receptor agonist; HbA(1c); Major adverse cardiovascular events; PIONEER; 6; Post hoc analysis; Semaglutide; SUSTAIN; Type; 2; diabetes;
D O I：
10.1093/eurheartj/ehae028
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1371 / 1374
页数：4
相关论文
共 50 条
  • [41] HbA1c, Coronary atheroma progression and cardiovascular outcomes
    Dykun, Iryna
    Bayturan, Ozgur
    Carlo, Julie
    Nissen, Steven E.
    Kapadia, Samir R.
    Tuzcu, E. Murat
    Nicholls, Stephen J.
    Puri, Rishi
    AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 9
  • [42] Calibration of the IQVIA Core Diabetes Model to the stroke outcomes from the SUSTAIN 6 cardiovascular outcomes trial of once-weekly semaglutide
    Berry, Sasha
    Chubb, Barrie
    Acs, Annabel
    Falla, Edel
    Verma, Akanksha
    Malkin, Samuel J. P.
    Hunt, Barnaby
    Palmer, Andrew J.
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 1019 - 1031
  • [43] Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk
    Husain, Mansoor
    Bain, Stephen C.
    Jeppesen, Ole K.
    Lingvay, Ildiko
    Sorrig, Rasmus
    Treppendahl, Marianne B.
    Vilsboll, Tina
    DIABETES OBESITY & METABOLISM, 2020, 22 (03): : 442 - 451
  • [44] Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline
    McGill, Janet B.
    Agarwal, Rajiv
    Anker, Stefan D.
    Bakris, George L.
    Filippatos, Gerasimos
    Pitt, Bertram
    Ruilope, Luis M.
    Birkenfeld, Andreas L.
    Caramori, Maria L.
    Brinker, Meike
    Joseph, Amer
    Lage, Andrea
    Lawatscheck, Robert
    Scott, Charlie
    Rossing, Peter
    FIDELIO-DKD Investigator
    FIGARO-DKD Investigator
    DIABETES OBESITY & METABOLISM, 2023, 25 (06): : 1512 - 1522
  • [45] The trials and tribulations of determining HbA1c targets for diabetes mellitus
    Klara R. Klein
    John B. Buse
    Nature Reviews Endocrinology, 2020, 16 : 717 - 730
  • [46] The effect of glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trials
    Leiter, Lawrence A.
    Bain, Stephen C.
    Bhatt, Deepak L.
    Buse, John B.
    Mazer, C. David
    Pratley, Richard E.
    Rasmussen, Soren
    Ripa, Maria Sejersten
    Vrazic, Hrvoje
    Verma, Subodh
    DIABETES OBESITY & METABOLISM, 2020, 22 (09): : 1690 - 1695
  • [47] Relationship between Baseline HbA1c, Change in HbA1c, and Clinical Outcomes in Type 2 Diabetes: A Comparison of Clinical Guidelines and Real-World Data
    Mcewan, Phil
    Gordon, Jason P.
    Evans, Marc
    Viana, Ricardo
    Paldanius, Paivi M.
    DIABETES, 2016, 65 : A575 - A575
  • [48] SUSTAIN 6: A POST-HOC ANALYSIS OF THE EFFECT OF SEMAGLUTIDE ON CARDIOVASCULAR OUTCOMES OVER TIME IN SUBJECTS WITH TYPE 2 DIABETES
    Bellary, S.
    Jodar, E.
    Seufert, J.
    Damgaard, L. H.
    Holst, A. Gaarsdal
    Leiter, L.
    ATHEROSCLEROSIS SUPPLEMENTS, 2018, 34 : E6 - E7
  • [49] SUSTAIN 6: a post-hoc analysis of the effect of semaglutide on cardiovascular outcomes over time in subjects with type 2 diabetes
    Jodar, E.
    Seufert, J.
    Damgaard, L. H.
    Holst, A. G.
    Leiter, L. A.
    EUROPEAN HEART JOURNAL, 2017, 38 : 819 - 819
  • [50] Association of Baseline HbA1c With Cardiovascular and Renal Outcomes: Analyses From DECLARE-TIMI 58
    Cahn, Avivit
    Wiviott, Stephen D.
    Mosenzon, Ofri
    Goodrich, Erica L.
    Murphy, Sabina A.
    Yanuv, Ilan
    Rozenberg, Aliza
    Bhatt, Deepak L.
    Leiter, Lawrence A.
    McGuire, Darren K.
    Wilding, John P. H.
    Gause-Nilsson, Ingrid A. M.
    Langkilde, Anna Maria
    Sabatine, Marc S.
    Raz, Itamar
    DIABETES CARE, 2022, 45 (04) : 938 - 946
12345